In breast invasive carcinoma (BRCA), prostate adenocarcinoma (PRAD), colon adenocarcinoma (COAD), and bladder cancer (BLCA), COL1A1 expression was higher in the advanced N stage than in the N0 stage (Fig. S1B–E). Here, COL1A1 is linked to bladder transitional cell carcinoma.